Market Cap 26.66M
Revenue (ttm) 1.41M
Net Income (ttm) -62.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,426.95%
Debt to Equity Ratio -0.93
Volume 3,365,805
Avg Vol 3,532,470
Day's Range N/A - N/A
Shares Out 84.61M
Stochastic %K 6%
Beta 0.18
Analysts Sell
Price Target $5.38

Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therap...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 619 3990
Address:
111 S. Wood Avenue, Unit #100, Iselin, United States
Alder77
Alder77 Apr. 29 at 8:42 PM
$OTLK yes RS
0 · Reply
s_f_f_72
s_f_f_72 Apr. 29 at 8:11 PM
$OTLK While the outcome of the FDR meeting remains uncertain, I’m convinced the company is about to deliver a major surprise. It feels like it will be either a significant breakthrough or a serious setback, there’s likely no middle ground here. Still holding 80k shares.
1 · Reply
nasser2254
nasser2254 Apr. 29 at 8:10 PM
$OTLK manipulation was at highest point, 3.34 million shares traded over one 3i% if penny.15 days for approval, get ready.
0 · Reply
Britbox
Britbox Apr. 29 at 7:52 PM
0 · Reply
Tonyboner
Tonyboner Apr. 29 at 7:34 PM
$OTLK They will need more money after 5 weeks at best
2 · Reply
Blatter
Blatter Apr. 29 at 7:29 PM
$OTLK $OCGN 100k and wait for may and the FDA💎🚀🚀!!! And lets go $OTLK
0 · Reply
TheTaurusBull38
TheTaurusBull38 Apr. 29 at 7:29 PM
$OTLK jumped out 300,000 shares. I’ll buy back at .19.
0 · Reply
Britbox
Britbox Apr. 29 at 6:53 PM
$OTLK It is highly likely that management has a Plan B that has not yet been disclosed to the public. The combination of tight cash runway, repeated small dilutive raises, strategic hiring, and communication discipline points to a company that is deliberately buying time while positioning itself for a higher-value strategic outcome (partnership or acquisition) rather than continuing as a standalone, cash-burning entity. The May FDR written decision and mid-May earnings will be the next critical windows where this Plan B may become visible.
0 · Reply
Alfadogg
Alfadogg Apr. 29 at 6:41 PM
$OTLK pop quiz: what is the only reason on earth that bear trolls post nastygrams?
0 · Reply
shark_finance
shark_finance Apr. 29 at 6:03 PM
$OTLK a lot bear ... We are close to something big 😀
1 · Reply
Latest News on OTLK
Outlook Therapeutics Announces Proposed Public Offering

Mar 23, 2026, 5:30 PM EDT - 5 weeks ago

Outlook Therapeutics Announces Proposed Public Offering


Outlook Therapeutics Announces New Employment Inducement Grants

Dec 26, 2025, 5:00 PM EST - 4 months ago

Outlook Therapeutics Announces New Employment Inducement Grants


Outlook Therapeutics Provides Update on Type A Meeting with FDA

Sep 29, 2025, 8:45 AM EDT - 7 months ago

Outlook Therapeutics Provides Update on Type A Meeting with FDA


Outlook Therapeutics Requests Type A Meeting with FDA

Sep 2, 2025, 8:35 AM EDT - 8 months ago

Outlook Therapeutics Requests Type A Meeting with FDA


FDA Rejects Outlook Therapeutics Eye Drug For Second Time

Aug 28, 2025, 11:15 AM EDT - 8 months ago

FDA Rejects Outlook Therapeutics Eye Drug For Second Time


Outlook Therapeutics Transcript: Status Update

Aug 28, 2025, 8:30 AM EDT - 8 months ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Transcript: Status Update

Jun 25, 2025, 12:00 PM EDT - 11 months ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Transcript: Study Update

Feb 3, 2025, 7:00 PM EST - 1 year ago

Outlook Therapeutics Transcript: Study Update


Outlook Therapeutics® Streamlines Operations

Dec 13, 2024, 4:30 PM EST - 1 year ago

Outlook Therapeutics® Streamlines Operations


Outlook Therapeutics Earnings Call Transcript: Q3 2024

Aug 14, 2024, 8:30 AM EDT - 1 year ago

Outlook Therapeutics Earnings Call Transcript: Q3 2024


Outlook Therapeutics Earnings Call Transcript: Q2 2024

May 16, 2024, 8:30 AM EDT - 2 years ago

Outlook Therapeutics Earnings Call Transcript: Q2 2024


Outlook Therapeutics Transcript: FDA Announcement

Aug 30, 2023, 8:30 AM EDT - 2 years ago

Outlook Therapeutics Transcript: FDA Announcement


Outlook Therapeutics Transcript: Investor Update

May 11, 2022, 1:00 PM EDT - 4 years ago

Outlook Therapeutics Transcript: Investor Update


Outlook Therapeutics Transcript: Study Update

Aug 3, 2021, 8:00 AM EDT - 5 years ago

Outlook Therapeutics Transcript: Study Update


Outlook Therapeutics Transcript: Clinical Day 2021

May 20, 2021, 11:00 AM EDT - 5 years ago

Outlook Therapeutics Transcript: Clinical Day 2021


Alder77
Alder77 Apr. 29 at 8:42 PM
$OTLK yes RS
0 · Reply
s_f_f_72
s_f_f_72 Apr. 29 at 8:11 PM
$OTLK While the outcome of the FDR meeting remains uncertain, I’m convinced the company is about to deliver a major surprise. It feels like it will be either a significant breakthrough or a serious setback, there’s likely no middle ground here. Still holding 80k shares.
1 · Reply
nasser2254
nasser2254 Apr. 29 at 8:10 PM
$OTLK manipulation was at highest point, 3.34 million shares traded over one 3i% if penny.15 days for approval, get ready.
0 · Reply
Britbox
Britbox Apr. 29 at 7:52 PM
0 · Reply
Tonyboner
Tonyboner Apr. 29 at 7:34 PM
$OTLK They will need more money after 5 weeks at best
2 · Reply
Blatter
Blatter Apr. 29 at 7:29 PM
$OTLK $OCGN 100k and wait for may and the FDA💎🚀🚀!!! And lets go $OTLK
0 · Reply
TheTaurusBull38
TheTaurusBull38 Apr. 29 at 7:29 PM
$OTLK jumped out 300,000 shares. I’ll buy back at .19.
0 · Reply
Britbox
Britbox Apr. 29 at 6:53 PM
$OTLK It is highly likely that management has a Plan B that has not yet been disclosed to the public. The combination of tight cash runway, repeated small dilutive raises, strategic hiring, and communication discipline points to a company that is deliberately buying time while positioning itself for a higher-value strategic outcome (partnership or acquisition) rather than continuing as a standalone, cash-burning entity. The May FDR written decision and mid-May earnings will be the next critical windows where this Plan B may become visible.
0 · Reply
Alfadogg
Alfadogg Apr. 29 at 6:41 PM
$OTLK pop quiz: what is the only reason on earth that bear trolls post nastygrams?
0 · Reply
shark_finance
shark_finance Apr. 29 at 6:03 PM
$OTLK a lot bear ... We are close to something big 😀
1 · Reply
DidYouReadThis
DidYouReadThis Apr. 29 at 5:54 PM
$OTLK How many people are turning 65 in Europe vs the US over the next 12 years? #HappyBirthday!
0 · Reply
DidYouReadThis
DidYouReadThis Apr. 29 at 5:44 PM
Dear $REGN, how much of a drop in earnings might you anticipate per year or over 12 years if $OTLK (EMA approved opthalmic bevacizumab for #WetAMD) receives #FDAapproval? Do you have any links with formulas or examples that are pretty close for estimating how much a drug is worth for an acquisition, vs licensing?
1 · Reply
farcanal
farcanal Apr. 29 at 5:31 PM
$OTLK Gee they really are hauling out all of the otherwise dormant old OTLK-centric, cross-ticker posting, self-liking accounts here today in the quest to now ATM-pump this back to 31c for round 2 of the warrant conversion and offload! Who will be joining us next from the annals of Outlook history??
0 · Reply
DidYouReadThis
DidYouReadThis Apr. 29 at 5:27 PM
$DJT friends, do you think #TheDonald might help get $OTLK or any other pharma stocks get #FDA approved this year? $OTLK is #EMA approved. What percent of the time is bevacizumab used off label? Who sponsored the CATT Trial? What drug is commonly used for Medicare, Medicaid, and VA wet AMD patients? What’s the market size of #WetAMD? What’s the market cap of $OTLK? What’s the market cap of $COR? What’s the market cap of Regeneron and Roche? If $OTLK earns FDA approval, what do you estimate for the buy out price?
0 · Reply
DidYouReadThis
DidYouReadThis Apr. 29 at 5:13 PM
$OTLK Why might a penny stock be hard to borrow pre-news and pre-May earnings?
0 · Reply
Tonyboner
Tonyboner Apr. 29 at 4:56 PM
$OTLK The New Convertible Promissory Note On January 31, 2025, we entered into the SPA, with Avondale Capital, LLC, or the Lender, pursuant to which we expect to issue to the Lender the New Note with a face amount of $33,100,000. The issuance of the New Note is expected to occur after the Annual Meeting, subject to the closing conditions outlined below. The New Note will initially bear interest at the prime rate (as published in the Wall Street Journal) plus 3% (subject to a floor of 9.5%) and will be scheduled to mature on July 1, 2026. We will have an obligation to repay at least $3,000,000 of the outstanding balance of the New Note for each calendar quarter beginning with the second calendar quarter of 2025 (subject to adjustment for conversions by the Lender and to payment of an exit fee of 7.5%), or the Quarterly Debt Reduction Obligations.
1 · Reply
Tonyboner
Tonyboner Apr. 29 at 4:52 PM
$OTLK Cash burn of -$14.94M per Q and they just raised 5 million, when is the next raise? end of next week ?
1 · Reply
Enea1977
Enea1977 Apr. 29 at 4:44 PM
$OTLK What matters is how it will be... if the stock was worthless, you and your fellow thugs wouldn't have been wasting time gloating about being right. If the stock will drops to 0.1, the only explanation will be that otlk is led by a poor guy of your same level. Lol!!!!
0 · Reply
janed102
janed102 Apr. 29 at 4:43 PM
$OTLK no pain no gain 😂
0 · Reply
MilkingAlgosEveryMonday
MilkingAlgosEveryMonday Apr. 29 at 4:32 PM
$OTLK we are here to gain or nain.
0 · Reply
AnalystLLM
AnalystLLM Apr. 29 at 4:11 PM
$OTLK everyday 3-4m volume, it means no volume
0 · Reply
Master_P_
Master_P_ Apr. 29 at 4:00 PM
$OTLK I have zero shares here, but these dudes bashing the stock here all day are lame as hell. Not a good investment? Move on. Weirdos.
3 · Reply